Chemotherapy for cancer patients who present late

被引：5

作者：

Bowcock, SJ ^{[1
]}

Shee, CD

Rassam, SMB

Harper, PG

机构：

[1] Queen Marys Sidcup NHS Trust, Sidcup DA14 6LT, Kent, England

[2] Guys & St Thomas Hosp NHS Trust, Dept Med Oncol, London SE1 9RT, England

来源：

BRITISH MEDICAL JOURNAL | 2004年 / 328卷 / 7453期

关键词：

D O I：

10.1136/bmj.328.7453.1430

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：1430 / 1432

页数：3

相关论文

共 19 条

[1]

[Anonymous], 2003, COCHRANE DB SYST REV

[2]

Archer V R, 1999, Oncologist, V4, P470

[3]

Buckman R, 1998, OXFORD TXB PALLIATIV, P145

[4] The treatment of acute leukaemia [J].

Burnett, AK ;

Eden, OB .

LANCET, 1997, 349 (9047) :270-275

[5] Small-cell lung cancer: Patients included in clinical trials are not representative of the patient population as a whole [J].

Cottin, V ;

Arpin, D ;

Lasset, C ;

Cordier, JF ;

Brune, J ;

Chauvin, F ;

Trillet-Lenoir, V .

ANNALS OF ONCOLOGY, 1999, 10 (07) :809-815

[6] A RANDOMIZED TRIAL OF PLANNED VERSUS AS REQUIRED CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER - A CANCER-RESEARCH-CAMPAIGN TRIAL [J].

EARL, HM ;

RUDD, RM ;

SPIRO, SG ;

ASH, CM ;

JAMES, LE ;

LAW, CS ;

TOBIAS, JS ;

HARPER, PG ;

GEDDES, DM ;

ERAUT, D ;

PARTRIDGE, MR ;

SOUHAMI, RL .

BRITISH JOURNAL OF CANCER, 1991, 64 (03) :566-572

[7] SYMPTOM RELIEF WITH MVP (MITOMYCIN-C, VINBLASTINE AND CISPLATIN) CHEMOTHERAPY IN ADVANCED NON-SMALL-CELL LUNG-CANCER [J].

ELLIS, PA ;

SMITH, IE ;

HARDY, JR ;

NICOLSON, MC ;

TALBOT, DC ;

ASHLEY, SE ;

PRIEST, K .

BRITISH JOURNAL OF CANCER, 1995, 71 (02) :366-370

[8] Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma:: Results of a multivariate analysis [J].

Gómez, H ;

Hidalgo, M ;

Casanova, L ;

Colomer, R ;

Pen, DLK ;

Otero, J ;

Rodríguez, W ;

Carracedo, C ;

Cortés-Funes, H ;

Vallejos, C .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) :2065-2069

[9]

HEIM ME, 1983, RECENT RES CANCER, V86, P37

[10] Clinical benefit from palliative chemotherapy in non-small cell lung cancer extends to the elderly and those with poor prognostic factors [J].

Hickish, TF ;

Smith, IE ;

O'Brien, MER ;

Ashley, S ;

Middleton, G .

BRITISH JOURNAL OF CANCER, 1998, 78 (01) :28-33